What We’re Reading: Medicaid Housing Support; AstraZeneca Cell Therapy Investment; Antismoking Campaign Relaunch

Medicaid Money Allocated Into Housing for the Homeless

At least 19 states across the US are funneling Medicaid dollars into housing initiatives aimed at tackling homelessness among the poorest and sickest Americans, according to Kaiser Health News. California leads the charge with a $12 billion investment, followed by efforts in states including Arizona ($550 million), Oregon (more than $1 billion), and Arkansas (approximately $100 million). However, although proponents argue that housing assistance can improve health outcomes and save taxpayer money, skeptics question whether this shift from traditional medical care is the best use of Medicaid funding.

AstraZeneca Invests $300 Million in Cell Therapy Facility

AstraZeneca has announced a $300 million investment in a new facility located in Rockville, Maryland, dedicated to the discovery and development of cell therapies, according to Reuters. This site is part of the latest investment for AstraZeneca, following partnerships with Quell Therapeutics, AbelZeta, and Cellectis, and the acquisition of Neogene Therapeutics, according to a recent press release. The move is expected to create over 150 jobs initially, focusing on manufacturing cell therapies for clinical trials, with potential expansion into other disease areas.

CDC Revives Antismoking Ad Campaign Targeting Menthol Cigarettes

The CDC has relaunched an antismoking advertising campaign with a focus on combatting menthol cigarette use, according to The Hill. Aimed at reducing smoking rates, particularly among minority communities, the campaign highlights the dangers of menthol cigarettes and the higher risk of addiction and health issues associated with them. This initiative underscores ongoing efforts to address tobacco-related disparities and promote public health awareness regarding menthol cigarette consumption.